Moreover, recent studies discovered TRIM28 as a possible tumor-class predictive biomarker, used to distinguish glioblastomas from lower grade gliomas, and from reference samples with a unique nanobody-based anti-proteome approach [22]. The gene discussed is TRIM28; the disease is glioma.